合成生物学开始比拼产业化规模 多家上市药企趁势布局

Group 1 - The core viewpoint is that synthetic biology is transitioning from technological innovation to industrial competition, with Zhejiang Haizheng Pharmaceutical establishing a subsidiary focused on becoming a leader in China's synthetic biology industry [1] - The establishment of Lunsing Synthetic Biology marks Haizheng Pharmaceutical's entry into the high-end synthetic biology sector, as stated by the company's chairman [1] - The synthetic biology sector is experiencing renewed interest among pharmaceutical companies, with several firms announcing related initiatives in June 2025 [1] Group 2 - Synthetic biology is seen as the third biotechnology revolution, addressing challenges faced in traditional chemical synthesis and natural product extraction [2] - The industry is currently at a critical stage of transitioning from technology validation to industrial implementation, with scaling and industrialization being core challenges [2] Group 3 - Companies with certain production capacity advantages are expected to dominate the current wave of synthetic biology [3] - Watson Bio is exploring the integration of artificial intelligence with its existing vaccine business, while Guoyao Modern is collaborating with universities on optimizing penicillin processes and developing key technologies for clavulanic acid synthesis [3] - Lunsing Synthetic Biology aims to leverage Haizheng Pharmaceutical's technological reserves in biotechnology, chemical synthesis, and microbial fermentation to explore new avenues in synthetic biology [3] Group 4 - Lunsing Synthetic Biology has a 110-acre industrial base and a fermentation capacity of 3,000 cubic meters, with a flexible production line for synthetic biology set to be operational soon [3] - An investment of 171 million yuan has been made for the construction of the production line, with the first synthetic biology product expected to be launched in August [3] - The company plans to focus on product lines related to bone health, liver protection, cardiovascular systems, and aesthetic health [3]